Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

Adhihetty PJ, Beal MF.

Neuromolecular Med. 2008;10(4):275-90. doi: 10.1007/s12017-008-8053-y. Epub 2008 Nov 13. Review.

2.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
3.

Functions and effects of creatine in the central nervous system.

Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR.

Brain Res Bull. 2008 Jul 1;76(4):329-43. doi: 10.1016/j.brainresbull.2008.02.035. Epub 2008 Mar 24. Review.

PMID:
18502307
4.

The neuroprotective role of creatine.

Klein AM, Ferrante RJ.

Subcell Biochem. 2007;46:205-43. Review.

PMID:
18652079
5.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
6.

Mitochondrial medicine for aging and neurodegenerative diseases.

Reddy PH.

Neuromolecular Med. 2008;10(4):291-315. doi: 10.1007/s12017-008-8044-z. Epub 2008 Jun 20. Review.

7.

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

Sas K, Robotka H, Toldi J, VĂ©csei L.

J Neurol Sci. 2007 Jun 15;257(1-2):221-39. Epub 2007 Apr 25. Review.

PMID:
17462670
8.

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders.

Tarnopolsky MA, Beal MF.

Ann Neurol. 2001 May;49(5):561-74. Review.

PMID:
11357946
9.

Mitochondrial diseases of the brain.

Chaturvedi RK, Flint Beal M.

Free Radic Biol Med. 2013 Oct;63:1-29. doi: 10.1016/j.freeradbiomed.2013.03.018. Epub 2013 Apr 6. Review.

PMID:
23567191
10.

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Allen PJ.

Neurosci Biobehav Rev. 2012 May;36(5):1442-62. doi: 10.1016/j.neubiorev.2012.03.005. Epub 2012 Mar 24. Review.

11.

[Role of creatine kinase and its substrates in the central nervous system in norm and in various pathologies].

Nersesova LS.

Zh Evol Biokhim Fiziol. 2011 Mar-Apr;47(2):120-7. Review. Russian.

PMID:
21598696
12.
13.

The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Lee J, Boo JH, Ryu H.

Adv Drug Deliv Rev. 2009 Nov 30;61(14):1316-23. doi: 10.1016/j.addr.2009.07.016. Epub 2009 Aug 27. Review.

14.
15.

Cerebral energetic effects of creatine supplementation in humans.

Pan JW, Takahashi K.

Am J Physiol Regul Integr Comp Physiol. 2007 Apr;292(4):R1745-50. Epub 2006 Dec 21.

16.

Neuroprotective effects of creatine.

Beal MF.

Amino Acids. 2011 May;40(5):1305-13. doi: 10.1007/s00726-011-0851-0. Epub 2011 Mar 30. Review.

PMID:
21448659
17.

Mitochondria, NO and neurodegeneration.

Beal MF.

Biochem Soc Symp. 1999;66:43-54. Review.

PMID:
10989656
18.

Neurodegeneration as a consequence of failed mitochondrial maintenance.

Karbowski M, Neutzner A.

Acta Neuropathol. 2012 Feb;123(2):157-71. doi: 10.1007/s00401-011-0921-0. Epub 2011 Dec 7. Review.

PMID:
22143516
19.

Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues.

Orsucci D, Mancuso M, Ienco EC, LoGerfo A, Siciliano G.

Curr Med Chem. 2011;18(26):4053-64. Review.

PMID:
21824087
20.

Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.

Burchell VS, Gandhi S, Deas E, Wood NW, Abramov AY, Plun-Favreau H.

Expert Opin Ther Targets. 2010 Apr;14(4):369-85. doi: 10.1517/14728221003652489. Review.

PMID:
20184395

Supplemental Content

Support Center